AlphaPod — Investment-podcast mention monitor

← newsroom

AI Drug Discovery · Neural engineering outperforms drug discovery for sensory/motor restoration — bypasses molecular heterogeneity

now playing · AI Drug Discovery

Brain-Computer Interfacestailwindscore 9/10max hodak

BCI is a category like pharma — multiple modalities for distinct applications, not a single product

Different BCI modalities (retinal implants, cortical threads, ultrasound, bio-hybrid) will serve different indications: vision restoration, motor decoding, neuromodulation (focus/sleep), an…

AI Drug Discoverytailwindscore 8/10max hodak

Neural engineering outperforms drug discovery for sensory/motor restoration — bypasses molecular heterogeneity

Drug discovery fails for complex degenerative diseases (e.g., blindness) because each molecular etiology differs and trials take a decade with high failure rates; neural engineering substit…

AI Infrastructuretailwindscore 8/10max hodak

AI and neuroscience representations converging — latent spaces in models mirror brain's object manifolds

Deep unification underway: representations in trained vision/language models structurally resemble neural population codes in inferotemporal cortex and other areas; neuroscience increasingl…

Longevity & Agingtailwindscore 7/10max hodak

First people to live to 1,000 may already be alive; 2035 event horizon for radical life extension

Convergence of BCI (restoring lost function) and AI (intelligence amplification) creates 'lateral options' that reframe aging not as inevitable decline but as treatable engineering challeng…